Matches in SemOpenAlex for { <https://semopenalex.org/work/W983860170> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W983860170 endingPage "2533" @default.
- W983860170 startingPage "2533" @default.
- W983860170 abstract "Abstract The BCR-ABL fusion gene results from the translocation t(9;22). It is the hallmark of chronic myeloid leukemia (CML) and is present in a poor-risk subgroup of precursor B cell acute lymphoblastic leukemia (ALL), which represents 25–30% of adult ALL and 3–5% of childhood ALL. Consequently the detection of the BCR-ABL aberration is of utmost importance for diagnosis and classification of leukemia patients and can also be used as marker for monitoring of BCR-ABL+ leukemias to evaluate treatment effectiveness. So far, the BCR-ABL aberration has been detected by cytogenetics, FISH or PCR, all techniques that are time consuming and require special facilities. We developed a simple flow cytometric bead assay for detection of the BCR-ABL fusion protein in cell lysates, using a bead-bound catching antibody against one side of the fusion protein and a fluorochrome-conjugated detection antibody against the other side of the fusion protein. The anti-BCR antibody was developed against a non-homologous region of ~80 amino acids, encoded by exon 1 in order to detect all know BCR-ABL variants, including p190, p210, and p230. The assay appeared to be specific and sufficiently sensitive to detect BCR-ABL proteins in leukemic cell lysates. However, protein stability problems were encountered when cell samples contained high frequencies of mature myeloid cells with high levels of protease activity, such as CML cells and granulocyte fractions. This problem could be significantly reduced by adding protease inhibitors to several steps of the immunobead assay. The immunobead assay was further developed and standardized by BD Biosciences into the Cytometric Bead Array (CBA) assay (BCR-ABL Protein Kit; BD Biosciences, San Jose, CA) for Research Use Only. Large scale testing of this kit in 9 diagnostic laboratories of the EuroFlow Consortium showed that the results of the flow cytometric BCR-ABL immunobead assay were fully concordant with the PCR results in a series of 83 freshly collected samples from newly diagnosed (n=75) or relapsed (n=8) leukemia patients: 13 CML patients, 53 ALL patients, and 17 acute myeloid leukemia (AML) patients (see table). All blood samples tested from 61 healthy controls were negative in the immunobead assay. BCR-ABL PCR assay BCR-ABL immunobead assay negative p190 p210 negative* weak* medium* high* * negative: MFI value <150; weak: MFI value ≥150 and <500; medium: MFI value ≥500 and <2000; high: MFI value ≥2000 Healthy controls (n=61) NT 61 0 0 0 Precursor-B-ALL - childhood (n=22) 22 0 0 22 0 0 0 - adult (n=19) 7 9 3 7 1 1 10 T-ALL (n=12) 12 0 0 12 0 0 0 AML (n=17) 17 0 0 17 0 0 0 CML (n=13) 1 1 11 1 5 4 3 We conclude that the flow cytometric immunobead assay is a fast and easy technique for specific detection of BCR-ABL proteins in leukemic cells. The assay is independent of the breakpoint position in the BCR gene, does not need special laboratory facilities other than a routine flow cytometer, provides results within several hours, and can be run in parallel to routine immunophenotyping. Since differentially labeled beads allow multiplexing, it will be possible to develop single tube assays for combined evaluation of multiple different fusion proteins, e.g. per disease category. Consequently, the flow cytometric immunobead assay can contribute to fast and easy diagnosis and classification of leukemias. If sufficient sensitivity can be reached, also monitoring of minimal residual disease becomes possible." @default.
- W983860170 created "2016-06-24" @default.
- W983860170 creator A5020466742 @default.
- W983860170 creator A5026103367 @default.
- W983860170 creator A5027341200 @default.
- W983860170 creator A5035606379 @default.
- W983860170 creator A5042546788 @default.
- W983860170 creator A5046473389 @default.
- W983860170 creator A5057708454 @default.
- W983860170 creator A5058731031 @default.
- W983860170 creator A5058764624 @default.
- W983860170 creator A5068490029 @default.
- W983860170 creator A5071962621 @default.
- W983860170 creator A5072104777 @default.
- W983860170 creator A5087808668 @default.
- W983860170 date "2008-11-16" @default.
- W983860170 modified "2023-10-09" @default.
- W983860170 title "Flow Cytometric Detection of BCR-ABL Fusion Proteins in Leukemia Patients Via An Immunobead Assay" @default.
- W983860170 doi "https://doi.org/10.1182/blood.v112.11.2533.2533" @default.
- W983860170 hasPublicationYear "2008" @default.
- W983860170 type Work @default.
- W983860170 sameAs 983860170 @default.
- W983860170 citedByCount "0" @default.
- W983860170 crossrefType "journal-article" @default.
- W983860170 hasAuthorship W983860170A5020466742 @default.
- W983860170 hasAuthorship W983860170A5026103367 @default.
- W983860170 hasAuthorship W983860170A5027341200 @default.
- W983860170 hasAuthorship W983860170A5035606379 @default.
- W983860170 hasAuthorship W983860170A5042546788 @default.
- W983860170 hasAuthorship W983860170A5046473389 @default.
- W983860170 hasAuthorship W983860170A5057708454 @default.
- W983860170 hasAuthorship W983860170A5058731031 @default.
- W983860170 hasAuthorship W983860170A5058764624 @default.
- W983860170 hasAuthorship W983860170A5068490029 @default.
- W983860170 hasAuthorship W983860170A5071962621 @default.
- W983860170 hasAuthorship W983860170A5072104777 @default.
- W983860170 hasAuthorship W983860170A5087808668 @default.
- W983860170 hasConcept C104317684 @default.
- W983860170 hasConcept C111829193 @default.
- W983860170 hasConcept C123894998 @default.
- W983860170 hasConcept C125418893 @default.
- W983860170 hasConcept C138626823 @default.
- W983860170 hasConcept C153911025 @default.
- W983860170 hasConcept C170493617 @default.
- W983860170 hasConcept C203014093 @default.
- W983860170 hasConcept C2778461978 @default.
- W983860170 hasConcept C2778729363 @default.
- W983860170 hasConcept C2778904597 @default.
- W983860170 hasConcept C40767141 @default.
- W983860170 hasConcept C42362537 @default.
- W983860170 hasConcept C43907098 @default.
- W983860170 hasConcept C502942594 @default.
- W983860170 hasConcept C55493867 @default.
- W983860170 hasConcept C62478195 @default.
- W983860170 hasConcept C86803240 @default.
- W983860170 hasConcept C95444343 @default.
- W983860170 hasConceptScore W983860170C104317684 @default.
- W983860170 hasConceptScore W983860170C111829193 @default.
- W983860170 hasConceptScore W983860170C123894998 @default.
- W983860170 hasConceptScore W983860170C125418893 @default.
- W983860170 hasConceptScore W983860170C138626823 @default.
- W983860170 hasConceptScore W983860170C153911025 @default.
- W983860170 hasConceptScore W983860170C170493617 @default.
- W983860170 hasConceptScore W983860170C203014093 @default.
- W983860170 hasConceptScore W983860170C2778461978 @default.
- W983860170 hasConceptScore W983860170C2778729363 @default.
- W983860170 hasConceptScore W983860170C2778904597 @default.
- W983860170 hasConceptScore W983860170C40767141 @default.
- W983860170 hasConceptScore W983860170C42362537 @default.
- W983860170 hasConceptScore W983860170C43907098 @default.
- W983860170 hasConceptScore W983860170C502942594 @default.
- W983860170 hasConceptScore W983860170C55493867 @default.
- W983860170 hasConceptScore W983860170C62478195 @default.
- W983860170 hasConceptScore W983860170C86803240 @default.
- W983860170 hasConceptScore W983860170C95444343 @default.
- W983860170 hasIssue "11" @default.
- W983860170 hasLocation W9838601701 @default.
- W983860170 hasOpenAccess W983860170 @default.
- W983860170 hasPrimaryLocation W9838601701 @default.
- W983860170 hasRelatedWork W1981740211 @default.
- W983860170 hasRelatedWork W198449594 @default.
- W983860170 hasRelatedWork W2020954035 @default.
- W983860170 hasRelatedWork W2054113320 @default.
- W983860170 hasRelatedWork W2168811961 @default.
- W983860170 hasRelatedWork W2371783991 @default.
- W983860170 hasRelatedWork W2418100779 @default.
- W983860170 hasRelatedWork W2603592479 @default.
- W983860170 hasRelatedWork W4323519313 @default.
- W983860170 hasRelatedWork W983860170 @default.
- W983860170 hasVolume "112" @default.
- W983860170 isParatext "false" @default.
- W983860170 isRetracted "false" @default.
- W983860170 magId "983860170" @default.
- W983860170 workType "article" @default.